Distal Spinal Muscular Atrophy: An Overlooked Etiology of Weaning Failure in Children with Respiratory Insufficiency

Abstract

Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is a rare autosomal recessive neuromuscular disorder that involves the anterior horn motor neurons. It is a disease with a poor prognosis presenting with progressive distal motor weakness and respiratory insufficiency from diaphragmatic paralysis followed by distal muscle weakness before 6 months of age. With the intent to spread the awareness of this rare and life-threatening disease, we report a 2.5-month-old female infant with a subsequent diagnosis of SMARD1, who was admitted in our pediatric intensive care unit with chief complaint of progressive respiratory distress and poor feeding.

Keywords

respiratory insufficiency - spinal muscular atrophy - diaphragmatic paralysis

• References

• 1 Messina MF, Messina S, Gaeta M. , et al. Infantile spinal muscular atrophy with respiratory distress type I (SMARD 1): an atypical phenotype and review of the literature. Eur J Paediatr Neurol 2012; 16 (01) 90-94
• 2 Chalançon M, Debillon T, Dieterich K, Commare MC. A rare cause of respiratory failure in infants: distal spinal-muscular atrophy 1 (DSMA1 or SMARD1) [Article in French]. Arch Pediatr 2012; 19 (10) 1082-1085
• 3 Wirth B. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat 2000; 15 (03) 228-237
• 4 Grohmann K, Varon R, Stolz P. , et al. Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1). Ann Neurol 2003; 54 (06) 719-724
• 5 van der Pol WL, Talim B, Pitt M, von Au K. 190 th ENMC international workshop: spinal muscular atrophy with respiratory distress/distal spinal muscular atrophy type 1: 11-13 May 2012, Naarden, The Netherlands. Neuromuscul Disord 2013; 23 (07) 602-609
• 6 Pitt M, Houlden H, Jacobs J. , et al. Severe infantile neuropathy with diaphragmatic weakness and its relationship to SMARD1. Brain 2003; 126 (Pt 12): 2682-2692
• 7 Giannopoulou EZ, Martin T, Wirth B, Yilmaz U, Gortner L, Meyer S. Tongue fasciculations in an infant with spinal muscular atrophy type 1. Clin Case Rep 2015; 3 (10) 832-834
• 8 Eckart M, Guenther UP, Idkowiak J. , et al. The natural course of infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1). Pediatrics 2012; 129 (01) e148-e156
• 9 Rudnik-Schöneborn S, Stolz P, Varon R. , et al. Long-term observations of patients with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1). Neuropediatrics 2004; 35 (03) 174-182
• 10 Majid A, Talat K, Colin L, Caroline R, Helen K, Christian G. Heterogeneity in spinal muscular atrophy with respiratory distress type 1. J Pediatr Neurosci 2012; 7 (03) 197-199
• 11 San Millan B, Fernandez JM, Navarro C, Reparaz A, Teijeira S. Spinal muscular atrophy with respiratory distress type 1 (SMARD1) Report of a Spanish case with extended clinicopathological follow-up. Clin Neuropathol 2016; 35 (02) 58-65
• 12 Mohan U, Misra VP, Britto J, Muntoni F, King RH, Thomas PK. Inherited early onset severe axonal polyneuropathy with respiratory failure and autonomic involvement. Neuromuscul Disord 2001; 11 (04) 395-399
• 13 Porro F, Rinchetti P, Magri F. , et al. The wide spectrum of clinical phenotypes of spinal muscular atrophy with respiratory distress type 1: a systematic review. J Neurol Sci 2014; 346 (1–2): 35-42
• 14 Joseph S, Robb SA, Mohammed S. , et al. Interfamilial phenotypic heterogeneity in SMARD1. Neuromuscul Disord 2009; 19 (03) 193-195
• 15 Pierson TM, Tart G, Adams D. , et al. Infantile-onset spinal muscular atrophy with respiratory distress-1 diagnosed in a 20-year-old man. Neuromuscul Disord 2011; 21 (05) 353-355
• 16 Hamilton MJ, Longman C, O'Hara A, Kirkpatrick M, McWilliam R. Growing up with spinal muscular atrophy with respiratory distress (SMARD1). Neuromuscul Disord 2015; 25 (02) 169-171
• 17 Giannini A, Pinto AM, Rossetti G. , et al. Respiratory failure in infants due to spinal muscular atrophy with respiratory distress type 1. Intensive Care Med 2006; 32 (11) 1851-1855
• 18 Butterfield RJ, Stevenson TJ, Xing L. , et al. Congenital lethal motor neuron disease with a novel defect in ribosome biogenesis. Neurology 2014; 82 (15) 1322-1330
• 19 Jędrzejowska M, Madej-Pilarczyk A, Fidziańska A. , et al. Severe phenotypes of SMARD1 associated with novel mutations of the IGHMBP2 gene and nuclear degeneration of muscle and Schwann cells. Eur J Paediatr Neurol 2014; 18 (02) 183-192
• 20 Vanoli F, Rinchetti P, Porro F, Parente V, Corti S. Clinical and molecular features and therapeutic perspectives of spinal muscular atrophy with respiratory distress type 1. J Cell Mol Med 2015; 19 (09) 2058-2066
• 21 Dominguez E, Marais T, Chatauret N. , et al. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. Hum Mol Genet 2011; 20 (04) 681-693
• 22 Valori CF, Ning K, Wyles M. , et al. Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy. Sci Transl Med 2010; 2 (35) 35ra42 . doi: 10.1126/scitranslmed.3000830